关节内注射KGN增强的BMSCs治疗大鼠膝骨关节炎
本研究探讨了功能化纳米氧化石墨烯递送KGN增强BMSCs的软骨形成能力,并在大鼠ACLT诱导的OA模型中评估关节内注射KGN增强BMSCs的疗效。结果表明,PPG-KGN可高效递送KGN至BMSCs,增强其体外软骨分化;在体内,PPG-KGN预处理的BMSCs可保护关节间隙狭窄、病理矿化、OA进展及OA诱导的疼痛,并改善组织再生。
要点
- PPG-KGN可高效递送KGN至BMSCs,增强其体外软骨分化能力。
- 在大鼠OA模型中,关节内注射PPG-KGN预处理的BMSCs可减轻OA进展和疼痛。
- 该策略可能为OA治疗提供新方法。
核心结论
- KGN增强的BMSCs表现出显著改善的软骨形成和关节软骨修复能力。
- 多功能纳米颗粒药物递送系统可能有益于干细胞治疗。
- 结果提供了逆转OA症状和病理生理的机会。
研究设计与样本
- controlled laboratory study。
- 体外实验评估PPG-KGN递送KGN至BMSCs及软骨分化。
- 体内实验采用大鼠ACLT诱导OA模型,分5组:normal、PBS、PPG-KGN、BMSCs、BMSCs+PPG-KGN。
- 术后6周和9周关节内注射,14周进行影像学、行为学和组织学分析。
主要发现
- PPG在孵育后前4小时内被快速摄取,12小时达到饱和,并积累于BMSCs的溶酶体和细胞质。
- PPG-KGN可提高KGN的细胞内递送效率,使BMSCs表现出显著高的软骨分化能力。
- PPG-KGN预处理的BMSCs有助于保护关节间隙狭窄、病理矿化、OA发展和OA诱导的疼痛,并改善组织再生。
临床怎么用
- 细胞内递送KGN以产生具有增强软骨潜能的BMSCs可能为OA治疗提供新方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In this study, we investigated the in vitro and in vivo chondrogenic capacity of kartogenin (KGN)-enhanced bone marrow-derived mesenchymal stem cells (BMSCs) for cartilage regeneration. PURPOSE: To determine (1) whether functionalized nanographene oxide (NGO) can effectively deliver KGN into BMSCs and (2) whether KGN would enhance BMSCs during chondrogenesis in vitro and in vivo in an animal model. STUDY DESIGN: Controlled laboratory study. METHODS: Functionalized NGO with line chain amine-terminated polyethylene glycol (PEG) and branched polyethylenimine (BPEI) were used to synthesize biocompatible NGO-PEG-BPEI (PPG) and for loading hydrophobic KGN molecules noncovalently via π-π stacking and hydrophobic interactions (PPG-KGN). Then, PPG-KGN was used for the intracellular delivery of hydrophobic KGN by simple mixing and co-incubation with BMSCs to acquire KGN-enhanced BMSCs. The chondrogenic efficacy of KGN-enhanced BMSCs was evaluated in vitro. In vivo, osteoarthritis (OA) was induced by anterior cruciate ligament transection in rats. A total of 5 groups were established: normal (OA treated with nothing), phosphate-buffered saline (PBS; intra-articular injection of PBS), PPG-KGN (intra-articular injection of PPG-KGN), BMSCs (intra-articular injection of BMSCs), and BMSCs + PPG-KGN (intra-articular injection of PPG-KGN-preconditioned BMSCs). At 6 and 9 weeks after the surgical induction of OA, the rats received intra-articular injections of PPG-KGN, BMSCs, or KGN-enhanced BMSCs. At 14 weeks after the surgical induction of OA, radiographic and behavioral evaluations as well as histological analysis of the knee joints were performed. RESULTS: The in vitro study showed that PPG could be rapidly uptaken in the first 4 hours after incubation, reaching saturation at 12 hours and accumulating in the lysosome and cytoplasm of BMSCs. Thus, PPG-KGN could enhance the efficiency of the intracellular delivery of KGN, which showed a remarkably high chondrogenic differentiation capacity of BMSCs. When applied to an OA model of cartilage injuries in rats, PPG-KGN-preconditioned BMSCs contributed to protection from joint space narrowing, pathological mineralization, OA development, and OA-induced pain, as well as improved tissue regeneration, as evidenced by radiographic, weightbearing, and histological findings. CONCLUSION: Our results demonstrate that KGN-enhanced BMSCs showed markedly improved capacities for chondrogenesis and articular cartilage repair. We believe that this work demonstrates that a multifunctional nanoparticle-based drug delivery system could be beneficial for stem cell therapy. Our results present an opportunity to reverse the symptoms and pathophysiology of OA. CLINICAL RELEVANCE: The intracellular delivery of KGN to produce BMSCs with enhanced chondrogenic potential may offer a new approach for the treatment of OA.
引用
- Zeng WN, Zhang Y, Wang D, et al. Intra-articular Injection of Kartogenin-Enhanced Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis in a Rat Model. Am J Sports Med. 2021. PMID: 34213976. doi:10.1177/03635465211023183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。